Drug:
Reaction: SEIZURE
20260101 - 20261231
No. 3701 - 3800
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 3701 | 26388366 |
EU |
27 | 1 |
Dermatitis atopic, Seizure, Withdrawal syndrome, Scab, Inflammatory pain, Inflammation, Gait disturbance, Topical steroid withdrawal reaction, Arthritis, Pain in extremity, Steroid dependence, Sleep disorder, Drug ineffective, Therapy cessation, Product prescribing error, |
||||
HYDROCORTISONE BUTYRATE, DESONIDE, DESONIDE, BETAMETHASONE DIPROPIONATE, BETAMETHASONE VALERATE, BETAMETHASONE VALERATE FOAM, DESONIDE, DESONIDE, DESONIDE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, |
||||
| 3702 | 26388414 |
|||
Pyrexia, Cough, Seizure, Hospitalisation, Product use issue, |
||||
FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, |
||||
| 3703 | 26404140 |
75 | 2 | |
Seizure, Fall, Head injury, Therapy interrupted, |
||||
CENOBAMATE, |
||||
| 3704 | 26379991 |
CO |
67 | 2 |
Bacteraemia, Malaise, Diabetes mellitus inadequate control, Haematuria, Seizure, Infection, |
||||
CAPLACIZUMAB, CAPLACIZUMAB, CAPLACIZUMAB, CAPLACIZUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, AZATHIOPRINE, CYCLOSPORINE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 3705 | 26380048 |
RU |
1 | |
Seizure, |
||||
| 3706 | 26380271 |
22 | ||
Hospitalisation, Seizure, Tremor, Overdose, |
||||
BRIVARACETAM, BRIVARACETAM INJECTION, BRIVARACETAM, BRIVARACETAM INJECTION, MIDAZOLAM, |
||||
| 3707 | 26380618 |
|||
Electrocardiogram QRS complex prolonged, Seizure, Overdose, |
||||
BUPROPION HYDROCHLORIDE, |
||||
| 3708 | 26380647 |
|||
Electrocardiogram QRS complex prolonged, Seizure, Ventricular tachycardia, Overdose, |
||||
BUPROPION HYDROCHLORIDE, |
||||
| 3709 | 26380658 |
|||
Electrocardiogram QRS complex prolonged, Seizure, Overdose, |
||||
BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, |
||||
| 3710 | 26380910 |
CN |
||
Neurotoxicity, Cytokine release syndrome, Neutropenia, Seizure, Febrile neutropenia, Lineage switch leukaemia, CSF lymphocyte count increased, CSF cell count increased, Blast cell count increased, Transformation to acute myeloid leukaemia, B-cell aplasia, Sepsis, Thrombocytopenia, Pancytopenia, Hepatotoxicity, Encephalopathy, Acute graft versus host disease, Myelosuppression, Tumour lysis syndrome, Graft versus host disease in skin, Chronic graft versus host disease oral, Human herpesvirus 6 encephalitis, Graft versus host disease in eye, Graft versus host disease in liver, Graft versus host disease in gastrointestinal tract, Device related bacteraemia, Chloroma, Immune effector cell-associated neurotoxicity syndrome, Bone marrow necrosis, Graft versus host disease, Chronic graft versus host disease in eye, Acute graft versus host disease in skin, Chronic graft versus host disease in skin, Tremor, Hypotension, Infection, Transplantation complication, Confusional state, Fibrin degradation products increased, Alanine aminotransferase increased, Aspartate aminotransferase increased, White blood cell count decreased, Pyrexia, Adverse event, Blast cell count decreased, CD19 lymphocytes decreased, Tachycardia, CD19 antigen loss, Venoocclusive disease, Infusion site haemorrhage, Nervous system disorder, Aphasia, |
||||
BLINATUMOMAB, |
||||
| 3711 | 26380935 |
GB |
13 | 1 |
Seizure, Musculoskeletal stiffness, Respiration abnormal, Dermatitis contact, Infusion site erythema, Skin abrasion, Somnolence, |
||||
IDURSULFASE, IDURSULFASE, IDURSULFASE, IDURSULFASE, IDURSULFASE, IDURSULFASE, IDURSULFASE, |
||||
| 3712 | 26380970 |
AR |
13 | 2 |
Seizure, |
||||
SOMATROPIN, SOMATROPIN, |
||||
| 3713 | 26381043 |
EU |
83 | 2 |
Hyponatraemia, Seizure, |
||||
| 3714 | 26381060 |
EU |
28 | 1 |
Seizure, Acute kidney injury, Rhabdomyolysis, Cerebral artery embolism, Brain oedema, Cerebral infarction, Coma, |
||||
SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, |
||||
| 3715 | 26381214 |
US |
2 | |
Seizure, Drug dependence, Contraindicated product administered, |
||||
DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE, BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE, |
||||
| 3716 | 26381688 |
US |
2 | |
Seizure, Seizure, Hospitalisation, Retching, Eructation, Underdose, |
||||
TROFINETIDE, TROFINETIDE, TROFINETIDE, |
||||
| 3717 | 26381781 |
KR |
2 | |
Seizure, Product use in unapproved indication, |
||||
PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, |
||||
| 3718 | 26381878 |
US |
2 | |
Generalised tonic-clonic seizure, Seizure, Dystonia, Breath holding, Faeces soft, Diarrhoea, Dyspnoea, Nasopharyngitis, Underdose, Product dose omission issue, |
||||
TROFINETIDE, TROFINETIDE, TROFINETIDE, TROFINETIDE, TROFINETIDE, TROFINETIDE, TROFINETIDE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, BRIVARACETAM, BRIVARACETAM INJECTION, CLONAZEPAM, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, DIAZEPAM, |
||||
| 3719 | 26382041 |
US |
14 | 1 |
Seizure, Middle insomnia, Vomiting, |
||||
TROFINETIDE, CLONIDINE, |
||||
| 3720 | 26382164 |
US |
2 | |
Seizure, Nausea, Vomiting, Influenza, Vomiting, Underdose, Product dose omission issue, Product dose omission issue, |
||||
TROFINETIDE, TROFINETIDE, TROFINETIDE, TROFINETIDE, |
||||
| 3721 | 26382244 |
42 | 1 | |
Seizure, Syncope, Circulatory collapse, Vomiting, |
||||
GADOBUTROL, |
||||
| 3722 | 26382731 |
45 | 2 | |
Seizure, |
||||
NALTREXONE, LEVETIRACETAM, |
||||
| 3723 | 26382812 |
2 | ||
Seizure, Therapy interrupted, Condition aggravated, Multiple sclerosis, |
||||
DALFAMPRIDINE, FINGOLIMOD HCL, FINGOLIMOD, FINGOLIMOD HYDROCHLORIDE, |
||||
| 3724 | 26382842 |
US |
38 | 2 |
Seizure, Syncope, Nausea, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 3725 | 26382888 |
US |
2 | |
Seizure, Fall, |
||||
DUPILUMAB, |
||||
| 3726 | 26382994 |
KR |
2 | |
Seizure, Product use in unapproved indication, |
||||
PREGABALIN, |
||||
| 3727 | 26383384 |
US |
61 | 2 |
Renal failure, Seizure, Pain, Occupational therapy, Memory impairment, Sepsis, Impaired driving ability, |
||||
ADALIMUMAB, UPADACITINIB, |
||||
| 3728 | 26383385 |
86 | 2 | |
Urinary tract infection, Seizure, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 3729 | 26383510 |
30 | ||
Hallucination, Seizure, Partial seizures, Simple partial seizures, Focal dyscognitive seizures, Loss of consciousness, Tunnel vision, Asthenia, Fatigue, Neuroprosthesis implantation, Memory impairment, Craniotomy, Adverse event, Head discomfort, Tinnitus, Aura, Product dose omission issue, |
||||
BRIVARACETAM, BRIVARACETAM INJECTION, BRIVARACETAM, BRIVARACETAM INJECTION, MIDAZOLAM, LORAZEPAM, TOPIRAMATE, OXCARBAZEPINE, |
||||
| 3730 | 26383526 |
US |
3 | 1 |
Seizure, Gastroenteritis viral, Urticaria, |
||||
FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, CANNABIDIOL, CLOBAZAM, |
||||
| 3731 | 26383762 |
GB |
32 | 2 |
Seizure, |
||||
| 3732 | 26383853 |
US |
12 | 2 |
Seizure, |
||||
CERLIPONASE ALFA, CLOBAZAM, ZONISAMIDE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, FAMOTIDINE, GEMFIBROZIL, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, LEUPROLIDE, DIAZEPAM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, PROPRANOLOL HYDROCHLORIDE, MELATONIN, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, |
||||
| 3733 | 26383871 |
US |
53 | 2 |
Hospitalisation, Brain oedema, Seizure, |
||||
| 3734 | 26384130 |
CA |
24 | |
Cardiac arrest, Electrocardiogram QT prolonged, Seizure, |
||||
LISDEXAMFETAMINE DIMESYLATE, |
||||
| 3735 | 26374017 |
US |
2 | |
Seizure, Hospitalisation, Seizure, |
||||
CANNABIDIOL, CANNABIDIOL, |
||||
| 3736 | 26374103 |
US |
2 | |
Seizure, |
||||
DEUTETRABENAZINE, |
||||
| 3737 | 26374247 |
US |
2 | |
Seizure, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 3738 | 26374398 |
AR |
1 | |
Seizure, Hemiparesis, |
||||
| 3739 | 26374470 |
US |
||
Seizure, |
||||
ISOTRETINOIN, ISOTRETINOIN, |
||||
| 3740 | 26374580 |
US |
8 | 1 |
Loss of consciousness, Seizure, Tremor, Musculoskeletal stiffness, Eye movement disorder, Dizziness, Nausea, Diarrhoea, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 3741 | 26374618 |
|||
Seizure, Fall, Orthostatic hypotension, Orthostatic hypertension, Confusional state, Off label use, Dizziness, Diarrhoea, Irritable bowel syndrome, |
||||
FENFLURAMINE, FENFLURAMINE, |
||||
| 3742 | 26374643 |
48 | ||
Seizure, Product prescribing issue, |
||||
BRIVARACETAM, LACOSAMIDE, |
||||
| 3743 | 26374665 |
AU |
2 | |
Seizure, |
||||
CARBAMAZEPINE, PHENOBARBITAL SODIUM, |
||||
| 3744 | 26375250 |
EU |
21 | 1 |
Seizure, Off label use, |
||||
LACOSAMIDE, ETHOSUXIMIDE, |
||||
| 3745 | 26375500 |
US |
2 | |
Pneumonia, Seizure, Infusion site haemorrhage, Pulmonary mass, Arthropod bite, Eye inflammation, Product dose omission issue, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, BUSPIRONE HYDROCHLORIDE, FLUTICASONE FUROATE, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, DESVENLAFAXINE SUCCINATE, FENTANYL, LEVOCETIRIZINE DIHYDROCHLORIDE, PYRIDOSTIGMINE BROMIDE, POLYETHYLENE GLYCOL 3350, LEVONORGESTREL, PRUCALOPRIDE, LEVOTHYROXINE SODIUM, BACLOFEN, CHLORZOXAZONE, CYANOCOBALAMIN, ERYTHROMYCIN, GABAPENTIN, ERGOCALCIFEROL, CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE, LEVALBUTEROL TARTRATE, NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE, |
||||
| 3746 | 26375800 |
CA |
||
Cardiomyopathy, Autoimmune hepatitis, Capillary leak syndrome, Encephalitis autoimmune, Multiple organ dysfunction syndrome, Seizure, Rebound effect, Cytokine release syndrome, Toxicity to various agents, Drug intolerance, Disseminated intravascular coagulation, General physical health deterioration, Ejection fraction decreased, Cervix carcinoma recurrent, Thyroid disorder, Generalised oedema, Off label use, Therapeutic response unexpected, Product ineffective, Drug ineffective, Drug ineffective for unapproved indication, |
||||
BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, PEMBROLIZUMAB, OCTREOTIDE ACETATE, OCTREOTIDE, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LACTULOSE, AXITINIB, AXITINIB, ALBUMIN HUMAN, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, FUROSEMIDE, FUROSEMIDE, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, AXITINIB, AXITINIB, FUROSEMIDE, FUROSEMIDE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISONE, PREDNISONE, RITUXIMAB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, ALBUMIN HUMAN, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LACTULOSE, OCTREOTIDE ACETATE, OCTREOTIDE, |
||||
| 3747 | 26375914 |
EU |
1 | |
Seizure, |
||||
| 3748 | 26375952 |
US |
68 | 2 |
Pharmacophobia, Syncope, Blood glucose abnormal, Seizure, Transient ischaemic attack, Loss of consciousness, Post-traumatic stress disorder, Multiple drug hypersensitivity, Expired product administered, Illness, Autonomic nervous system imbalance, Blood pressure decreased, Diabetic autonomic neuropathy, Cortisol increased, Headache, Blood glucose increased, Glycosylated haemoglobin increased, Blood magnesium increased, Stress, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, MAGNESIUM, |
||||
| 3749 | 26376116 |
4 | 1 | |
Brain injury, Subdural effusion, Dyskinesia, Drug withdrawal syndrome, Seizure, |
||||
PROPOFOL, ROCURONIUM BROMIDE, ROCURONIUM, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, ISOFLURANE, CLONIDINE, MORPHINE, FENTANYL, |
||||
| 3750 | 26376277 |
VN |
60 | 1 |
Cardiac arrest, Coma, Seizure, Shock, Lactic acidosis, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ALCOHOL, ETHYL ALCOHOL, ISOPROPYL ALCOHOL, |
||||
| 3751 | 26376508 |
US |
62 | 2 |
Seizure, |
||||
TUCATINIB, |
||||
| 3752 | 26376772 |
US |
52 | 2 |
Sepsis, Device related infection, Surgery, Seizure, Systemic lupus erythematosus, Rheumatoid arthritis, Headache, Product dose omission issue, |
||||
ABALOPARATIDE, ALPRAZOLAM, AMLODIPINE BESYLATE, BUPRENORPHINE HYDROCHLORIDE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, OXYBUTYNIN CHLORIDE, PREDNISONE, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, RIVAROXABAN, TIRZEPATIDE, |
||||
| 3753 | 26378011 |
65 | 1 | |
Seizure, Infusion related reaction, |
||||
| 3754 | 26378732 |
US |
||
Seizure, Cerebral disorder, |
||||
FENTANYL CITRATE, |
||||
| 3755 | 26378786 |
US |
14 | 1 |
Urinary retention, Seizure, |
||||
CANNABIDIOL, CLOBAZAM, LEVETIRACETAM, TOPIRAMATE, |
||||
| 3756 | 26378971 |
CA |
62 | 2 |
Asthma, Bone pain, Bronchitis, Chest discomfort, Chronic obstructive pulmonary disease, Drug dependence, Dyspnoea, Exercise tolerance decreased, Full blood count abnormal, Gait disturbance, Heart rate increased, Illness, Joint swelling, Loss of personal independence in daily activities, Lung adenocarcinoma stage IV, Malaise, Metastases to central nervous system, Pneumothorax, Seizure, Sleep disorder due to a general medical condition, Steroid dependence, Therapeutic product effect incomplete, Wheezing, |
||||
BUDESONIDE, BUDESONIDE, BUDESONIDE, ALBUTEROL SULFATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, CALCIUM CARBONATE, ANTACID, MEPOLIZUMAB, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OXYGEN, 0XYGEN, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, RISEDRONATE SODIUM, ERGOCALCIFEROL, |
||||
| 3757 | 26379096 |
|||
Seizure, Agitation, Mood altered, Anxiety, |
||||
LEVETIRACETAM, MIDAZOLAM, BRIVARACETAM, PRIMIDONE, |
||||
| 3758 | 26379133 |
|||
Seizure, Overdose, |
||||
BRIVARACETAM, BRIVARACETAM INJECTION, MIDAZOLAM, |
||||
| 3759 | 26379252 |
9 | ||
Seizure, Nausea, Vomiting, Insomnia, Liquid product physical issue, Syringe issue, |
||||
FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, |
||||
| 3760 | 26379370 |
US |
42 | 2 |
Seizure, Migraine, Depression, Visual impairment, Polycystic ovarian syndrome, General physical health deterioration, |
||||
UPADACITINIB, LACOSAMIDE, VORTIOXETINE, QUETIAPINE, DEXMETHYLPHENIDATE HYDROCHLORIDE, BRIVARACETAM, OXYCODONE, OMEPRAZOLE MAGNESIUM, ZINC OXIDE, PACIFICA ULTRA CC CREAM RADIANT FOUNDATION SPF 30 WARM/LIGHT, ZINC OXIDE OINTMENT, PACIFICA ULTRA CC CREAM RADIANT FOUNDATION SPF 30 WARM/TAN, ZINC OXIDE 20%, SKIN PROTECTANT, PACIFICA ULTRA CC CREAM RADIANT FOUNDATION SPF 30 NATURAL/MEDIUM, PACIFICA ULTRA CC CREAM RADIANT FOUNDATION SPF 30 COOL/DEEP, MINERAL SUNSHIELD UNIVERSAL TINT BROAD SPECTRUM SPF 30 SUNSCREEN, ERGOCALCIFEROL, TIRZEPATIDE, DICLOFENAC SODIUM, BIOTIN, ALBUTEROL SULFATE, ALBUTEROL, NEMOLIZUMAB-ILTO, CETIRIZINE HYDROCHLORIDE, OXYMETAZOLINE HYDROCHLORIDE, LINACLOTIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 3761 | 26379414 |
TR |
12 | 1 |
Posterior reversible encephalopathy syndrome, Seizure, Blood pressure increased, Acute graft versus host disease, Off label use, |
||||
CYCLOSPORINE, METHOTREXATE, METHOTREXATE SODIUM, RUXOLITINIB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, ETOPOSIDE, AMPHOTERICIN B, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, LINEZOLID, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, FOSCARNET SODIUM, MUPIROCIN, MUPIROCIN CALCIUM, |
||||
| 3762 | 26379567 |
CA |
54 | |
Hysterectomy, Syncope, Seizure, Post procedural complication, Post procedural infection, Dizziness, Blood pressure increased, |
||||
EPTINEZUMAB-JJMR, EPTINEZUMAB-JJMR, GABAPENTIN, |
||||
| 3763 | 26379568 |
US |
13 | |
Seizure, Malaise, Prescribed overdose, |
||||
VIGABATRIN, CETIRIZINE HYDROCHLORIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, LACOSAMIDE, FLUTICASONE PROPIONATE, DIAZEPAM, MIDAZOLAM, |
||||
| 3764 | 26379664 |
US |
74 | 2 |
Musculoskeletal disorder, Delusion, Parkinson^s disease, Cognitive disorder, Contusion, Weight decreased, Sensorimotor disorder, Gait inability, Failure to thrive, Gait disturbance, Seizure, Product storage error, Blood potassium decreased, Hallucination, Urinary tract infection, Muscular weakness, Feeding disorder, Fluid intake reduced, Movement disorder, General physical health deterioration, Dysarthria, Depression, Anal incontinence, Urinary incontinence, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, MELATONIN, ERGOCALCIFEROL, PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, TIZANIDINE HYDROCHLORIDE, AMLODIPINE BESYLATE, QUETIAPINE, LACOSAMIDE, LACOSAMIDE, DOCUSATE SODIUM, SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, CARBIDOPA AND LEVODOPA, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, SERTRALINE HYDROCHLORIDE, CYANOCOBALAMIN, |
||||
| 3765 | 26379669 |
CA |
71 | 1 |
Seizure, Drug interaction, |
||||
BUPROPION, BUPROPION, CITALOPRAM, CITALOPRAM HYDROBROMIDE, ROSUVASTATIN, EXTENDED PHENYTOIN SODIUM, FOLIC ACID, METHOTREXATE, METHOTREXATE SODIUM, PANTOPRAZOLE, |
||||
| 3766 | 26379940 |
IL |
78 | 1 |
Seizure, |
||||
| 3767 | 26382056 |
13 | 2 | |
Seizure, Skin discolouration, Nonspecific reaction, Pulse absent, Pulse abnormal, Respiration abnormal, Pallor, Therapy cessation, |
||||
MIDAZOLAM, ZONISAMIDE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, |
||||
| 3768 | 26382256 |
13 | 2 | |
Seizure, |
||||
METHYLPHENIDATE, METHYLPHENIDATE HYDROCHLORIDE, |
||||
| 3769 | 26368829 |
26 | ||
Pericardial effusion, Seizure, Left atrial enlargement, Right atrial enlargement, Decreased appetite, Pyrexia, Headache, |
||||
CANNABIDIOL, ZONISAMIDE, BRIVARACETAM, BRIVARACETAM INJECTION, PERAMPANEL, PHENOBARBITAL, |
||||
| 3770 | 26369120 |
54 | ||
Seizure cluster, Seizure, Product availability issue, Therapy interrupted, Product use in unapproved indication, |
||||
LACOSAMIDE, LACOSAMIDE, MIDAZOLAM, |
||||
| 3771 | 26369255 |
US |
46 | 1 |
Seizure, Drug ineffective, |
||||
GLATIRAMER ACETATE, DIMETHYL FUMARATE, |
||||
| 3772 | 26369588 |
US |
16 | |
Seizure, Overdose, Loss of consciousness, |
||||
ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 3773 | 26369622 |
CA |
||
Epilepsy, Seizure, Coma, Off label use, Intentional product use issue, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, CLOBAZAM, FOLIC ACID, LEVOTHYROXINE SODIUM, DIVALPROEX SODIUM, |
||||
| 3774 | 26369636 |
US |
67 | 2 |
Seizure, |
||||
NATALIZUMAB, |
||||
| 3775 | 26369914 |
US |
6 | 2 |
Seizure, Neurofibromatosis, Astrocytoma, Ankle fracture, Injection site swelling, Weight decreased, Urinary tract infection, Skin hyperpigmentation, Mobility decreased, White blood cells urine positive, Bacterial test positive, White blood cells urine positive, |
||||
ASFOTASE ALFA, |
||||
| 3776 | 26370097 |
20 | ||
Seizure, Product distribution issue, Therapy interrupted, Incorrect dose administered, |
||||
BRIVARACETAM, BRIVARACETAM INJECTION, BRIVARACETAM, BRIVARACETAM INJECTION, |
||||
| 3777 | 26370168 |
US |
84 | 2 |
Death, Seizure, |
||||
BRENSOCATIB, |
||||
| 3778 | 26370273 |
US |
26 | 1 |
Abnormal behaviour, Skin discolouration, Headache, Screaming, Functional gastrointestinal disorder, Constipation, Altered state of consciousness, Volvulus, Head banging, Seizure, |
||||
STIRIPENTOL, STIRIPENTOL, STIRIPENTOL, STIRIPENTOL, CLOBAZAM, CLOBAZAM, DIVALPROEX SODIUM, DIVALPROEX SODIUM, |
||||
| 3779 | 26370493 |
CO |
23 | 2 |
Overdose, Off label use, Seizure, Pain, |
||||
HEMIN, HEMIN, |
||||
| 3780 | 26370583 |
US |
71 | 1 |
Death, Pneumonia, Seizure, Neoplasm malignant, |
||||
AMIFAMPRIDINE PHOSPHATE, AMIFAMPRIDINE PHOSPHATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, AMLODIPINE, FERROUS SULFATE, LEVETIRACETAM, LATANOPROST, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, OXYCODONE, PANTOPRAZOLE SODIUM, |
||||
| 3781 | 26370710 |
EU |
||
Cardiac arrest, Atrioventricular block complete, Seizure, Syncope, Bradyarrhythmia, |
||||
TICAGRELOR, TICAGRELOR, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 3782 | 26370901 |
US |
2 | |
Overdose, Suicide attempt, Drug dependence, Intentional product misuse, Seizure, Abnormal behaviour, Eating disorder, |
||||
DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 3783 | 26371048 |
US |
1 | |
Seizure, Gait disturbance, Somnolence, Illness, Treatment noncompliance, |
||||
ESLICARBAZEPINE ACETATE, ESLICARBAZEPINE ACETATE, |
||||
| 3784 | 26371252 |
US |
67 | 1 |
Completed suicide, Intentional overdose, Hypotension, Seizure, |
||||
BACLOFEN, ZOLPIDEM TARTRATE, |
||||
| 3785 | 26371381 |
US |
1 | |
Seizure, Head injury, |
||||
ABALOPARATIDE, ALPRAZOLAM, GABAPENTIN, GUANFACINE HYDROCHLORIDE, GUANFACINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, OXYCODONE HYDROCHLORIDE, OXYCODONE, QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 3786 | 26371439 |
KR |
18 | 1 |
Seizure, |
||||
IPRATROPIUM BROMIDE, |
||||
| 3787 | 26371445 |
CA |
||
Seizure, |
||||
| 3788 | 26371704 |
US |
2 | |
Tardive dyskinesia, Condition aggravated, Seizure, Insomnia, Ill-defined disorder, Off label use, |
||||
HYOSCYAMINE SULFATE, |
||||
| 3789 | 26371892 |
US |
86 | |
Seizure, Product availability issue, |
||||
RUXOLITINIB, FISH OIL, LEVETIRACETAM, RIVAROXABAN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, PANTOPRAZOLE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
| 3790 | 26371988 |
US |
1 | |
Seizure, Photosensitivity reaction, |
||||
CARBAMAZEPINE, CARBAMAZEPINE, LEVETIRACETAM, |
||||
| 3791 | 26371994 |
BR |
||
Seizure, Liquid product physical issue, Product colour issue, |
||||
OXCARBAZEPINE, CANNABIDIOL, |
||||
| 3792 | 26372324 |
US |
2 | 1 |
Off label use, Seizure, |
||||
STIRIPENTOL, STIRIPENTOL, STIRIPENTOL, STIRIPENTOL, STIRIPENTOL, STIRIPENTOL, FENFLURAMINE, FENFLURAMINE, LEVETIRACETAM, LEVETIRACETAM, CANNABIDIOL, CANNABIDIOL, CLOBAZAM, CLOBAZAM, |
||||
| 3793 | 26372529 |
US |
2 | |
Seizure, Product availability issue, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, ALPRAZOLAM, ESCITALOPRAM, ARIPIPRAZOLE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, |
||||
| 3794 | 26372614 |
CA |
71 | 1 |
Drug interaction, Seizure, |
||||
BUPROPION, BUPROPION, CITALOPRAM, CITALOPRAM HYDROBROMIDE, ROSUVASTATIN, EXTENDED PHENYTOIN SODIUM, FOLIC ACID, METHOTREXATE, METHOTREXATE SODIUM, PANTOPRAZOLE, ERGOCALCIFEROL, |
||||
| 3795 | 26373280 |
EU |
72 | 1 |
Neurotoxicity, Loss of consciousness, Seizure, Epistaxis, Anaemia, Thrombotic microangiopathy, Neuropathy peripheral, Intestinal transit time abnormal, Hypertension, Urinary incontinence, Thrombocytopenia, Oedema, Blood pressure decreased, Tachycardia, Diarrhoea, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), LANSOPRAZOLE, |
||||
| 3796 | 26373367 |
US |
30 | 2 |
Syncope, Seizure, Vomiting, |
||||
EPINEPHRINE, EPINEPHRINE, ADRENALINUM, |
||||
| 3797 | 26373486 |
EG |
||
Seizure, Concussion, Fall, |
||||
| 3798 | 26373699 |
US |
56 | 1 |
Seizure, |
||||
DIROXIMEL FUMARATE, |
||||
| 3799 | 26376641 |
36 | 2 | |
Seizure, Withdrawal syndrome, |
||||
| 3800 | 26376713 |
31 | 1 | |
Seizure, |
||||
LACOSAMIDE, LACOSAMIDE, LACOSAMIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30
